SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Pump's daily trading recs, emphasis on short selling -- Ignore unavailable to you. Want to Upgrade?

To: rupers who wrote (5572)9/7/2001 9:05:05 AM
From: Art Baeckel  Read Replies (1) | Respond to of 6873
 
ITWO, Shorting 2000 of these puppies @4.90!!!!

07:53 ET i2 Technologies (ITWO) 5.11: Banc of America Sec. views news that Kmart (KM) will restructure its
supply chain operations as a negative for ITWO (news out yesterday). Kmart is taking $130 mln in charges to write off
supply chain planning software from ITWO and supply chain execution software from EXE Technologies (EXEE).
According to firm, showcase customer failure, compounded with MANU miss, does not bode well for ITWO's Sept
and Dec. quarters.

ART



To: rupers who wrote (5572)9/7/2001 12:28:50 PM
From: rupers  Respond to of 6873
 
MATX - Follow up. It ain't looking good for MATX.

Trading halted before start of trading today. Maybe that Hedge Fund's consultant(who recommended the Fund dump its MATX shares) was worth his fee.

From Briefing.com:

11:04 ET Matrix Pharm (MATX) 6.79 unch (halted): Stock halted ahead of FDA panel comments on company's IntraDose Injectable Gel New Drug Application. Hearing reports that report does not favor approval of the product.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News